期刊文献+

血小板检测联合APACHEⅡ评分系统对心脏外科重症监护病房患者预后的评估价值分析 被引量:5

The Value of Platelet Counts in the Prognosis of Prognostic Evaluation of ICU Patients of Cardiac Surgery
下载PDF
导出
摘要 目的 探讨血小板检测联合急性生理学和慢性健康状况评定标准Ⅱ(acute physiologic and chronic health evaluationⅡ,APACHEⅡ)对心脏外科重症监护病房(CSICU)患者预后的评估价值。方法 收集2013年12月1日—2014年11月30日沈阳军区总医院CSICU患者2340例,均取术后次日清晨空腹肘静脉血测定血小板计数,并行24 h APACHEⅡ评分测定。根据APACHEⅡ评分分为〈15分、15-24分、25-34分、〉34分组,根据预后分为存活组和死亡组,比较各组血小板水平差异。另根据血小板计数分为血小板正常组与血小板减少组,分析两组APACHEⅡ评分的差异及其二者的相关性。结果 不同APACHEⅡ评分组血小板计数比较,15-24分组〉25-34分组〉25-34分组(P均〈0.05)。APACHEⅡ评分与预计病死率及实际病死率分别呈正相关(r=0.87,P=0.000;r=0.91,P=0.000)。死亡组APACHEⅡ评分显著高于生存组,血小板计数显著低于存活组,差异均有统计学意义(P〈0.01)。血小板减少组APACHEⅡ评分、病死率均显著高于血小板正常组,住CSICU时间长于血小板正常组,差异均有统计学意义(P〈0.05或P〈0.01)。相关性分析显示,患者血小板计数随APACHEⅡ评分的增加而减少,二者呈显著负相关(r=-0.729,P=0.000)。结论 CSICU患者血小板计数与APACHEⅡ评分存在相关性,二者结合可应用于CSICU围术期患者早期病情严重程度及预后评估,可前瞻性指导临床治疗,最大限度提高医疗质量,降低病死率。 Objective To investigate the evaluation value of platelet counts and acute physiology and chronic health evaluation Ⅱ (APACHEⅡ ) score on prognosis of patients admitted to Cardiac Surgery Intensive Care Unit. Methods 2340 cases of CSICU were collected in the General Hospital of Shenyang Military Area Command during December 1, 2013 and November 30, 2014. The blood platelet counts were measured in the first postoperative morning fasting venous blood of patients, at the same time APACHE II was scored within 24 hours after admission. The patients were divided into 4 groups: 〈 15 score, 15-24 score, 25-34 score, and 〉 34 score according to APACHE Ⅱ scores. All the patients were divided into two groups based on their prognosis:the survival group and the death group. The platelet levels in each group were analyzed and compared. According to the level of platelet counts, all the patients were divided into normal group and thrombocytopenia group. The relationships between APACHE Ⅱ score and platelet count were analyzed. Results The platelet counts in each group were compared, 15-24 score group 〉 25-34 score group 〉 34 score group 〉 34 score group ( P 〈 0.05 ). The APACHE Ⅱ score in the death group was significantly higher than that in the survival group, the platelet counts were significantly lower than that in the survival group, and the difference was statistically significant (P 〈 0.01 ). The APACHE Ⅱ score and mortality rate of the thrombocytopenia group were significantly higher than those of the normal group, and the CSICU time was longer than that of the normal group, and the difference was statistically significant (P 〈 0.05 or P 〈 0.01 ). Conclusion The level of platelet counts is related to APACHE Ⅱ score of patients admitted to Cardiac Surgery Intensive Care Unit. The combination of the two can be applied in the evaluation of the severity of the early disease in patients with CSICU, and prospective guidance for clinical treatment, and to maximize the quality of medical treatment and reduce the mortality rate.
出处 《临床误诊误治》 2016年第7期67-70,共4页 Clinical Misdiagnosis & Mistherapy
基金 中国博士后科学基金资助项目(2013M542568)
关键词 心脏外科手术 预后 血小板计数 急性生理学和慢性健康状况评分 Cardiac surgical procedure Prognosis Platelet count APACHE
  • 相关文献

参考文献19

二级参考文献74

  • 1邓懋清.血小板功能检测及其临床应用[J].中国医药指南,2008,6(17):148-150. 被引量:6
  • 2曾琦,邢柏.危重病患者血乳酸水平的变化与APACHEⅡ评分的关系[J].中国热带医学,2006,6(3):466-467. 被引量:13
  • 3Ruggeri ZM.Platelets in atherothrombosis[J],Nat Med,2002,8(11): 1227-1234.
  • 4Roth GJ,Stanford N,Majerus PW.Acetylation of prostaglandin synthase by aspirin[J].Proc Natl Acad Sci USA,1975,72(8):3073-3076.
  • 5Gurbel PA,Becker RC,Mann KG,et al.Platelet function monitoring in patients with coronary artery disease[J].J Am Coil Cardiol,2007, 50(19):1822-1834.
  • 6Gabbasov ZA,Popov EG,Gavrilov IY, et al.Platelet aggregation: the use of optical density fluctuations to study microaggregation formation in platelet suspension[J].Thromb Res,1989,54(3): 215 -223.
  • 7Nurden AT, Macchi L,Bihour C,et al.Makers of platelet activation in coronary heart disease patienrs[J].Eur J Clin Invest,1994,24 (Suppl 1):42-45.
  • 8Cahill MR,Macey MG,Dawson JR, et al.Platelet surface activation antigen expression at baseline and during elective angioplasty in patients with mild to moderate coronary artery disease[J].Blood Coagul Fibrinol, 1996,7(2): 165-168.
  • 9Eikelboom JW, Hirsh J,Weitz JI,et al.Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction,stroke,or cardiovascular death in patients at high risk for cardiovascular events[J].Circulation,2002,105(14): 1650-1655.
  • 10Andersen K,Hulren M,Arnesen H,et al.Aspirin nonresponsiveness as measured by PFA-100 in patients with coronary artery disease [J].Thromb Res,2003,108(1):37-42.

共引文献43

同被引文献49

引证文献5

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部